Inventor · disambiguated record
Philip Gotwals
Also filed as: GOTWALS PHILIP · GOTWALS PHILIP J
6 granted patents·6 pending applications·79 citations·filing 2000–2013
84Inventor score
Top patents by PatentIndex Score
12 records- 0190US6652856B2Method for the treatment of fibrosisBIOGEN INC·Filed 2002·Granted Nov 25, 2003·34 cites·8 claims
- 0286US8084031B2Method for the treatment of inflammatory disordersGOTWALS PHILIP·Filed 2008·Granted Dec 27, 2011·7 cites·15 claims
- 0386US7462353B2Method for the treatment of inflammatory disordersBIOGEN IDEC INC·Filed 2005·Granted Dec 9, 2008·12 cites·13 claims
- 0486US6955810B2Method for the treatment of inflammatory disordersBIOGEN IDEC INC·Filed 2001·Granted Oct 18, 2005·20 cites·7 claims
- 0584US8557240B2Method for the treatment of inflammatory disordersGOTWALS PHILIP·Filed 2011·Granted Oct 15, 2013·6 cites·20 claims
- 0659US9902774B2Method for the treatment of inflammatory disordersBIOGEN MA INC·Filed 2013·Granted Feb 27, 2018·0 cites·44 claims
- 0753US2005281818A1Method for the treatment of fibrosisBIOGEN IDEC INC·Filed 2005·Application pending·0 cites
- 0851US2004037827A1Method for the treatment of fibrosisFiled 2003·Application pending·0 cites
- 0944US2007048321A1Method for the treatment of fibrosisGOTWALS PHILIP J·Filed 2006·Application pending·0 cites
- 1038US2003124726A1Global expression analysis of extracellular matrix-integrin interactions in monocytesFiled 2001·Application pending·0 cites
- 1138US2002004037A1Variant type II TGF-beta receptor fusion proteins and methodsFiled 2000·Application pending·0 cites
- 1237US2005203022A1Type II TGF-beta receptor/immunoglobulin constant region fusion proteinsBIOGEN IDEC INC·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →